HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Orthostatic hypotension as an early finding in Parkinson's disease.

Abstract
Patients with Parkinson's disease (PD) commonly have clinically significant orthostatic hypotension (OH). In such patients PD+OH might be confused with multiple system atrophy (MSA), in which OH is a frequent finding, or with pure autonomic failure (PAF), if OH preceded clinical manifestations of the movement disorder. This study addressed whether OH can occur as an early finding in PD+OH. Historical data were analyzed from 35 patients with PD+OH evaluated at the NIH. OH was considered early if the patient had OH before, concurrent with, or starting within 1 year after onset of a symptomatic movement disorder. MSA was excluded by myocardial 6-[(18)F]fluorodopamine-derived radioactivity more than 2 standard deviations below the normal mean. Among the 35 PD+OH patients, 21 (60 %) had documentation of OH as an early finding. In 4 such patients, OH had preceded parkinsonism, and in 4 others, OH had dominated the early clinical picture, even after cessation of levodopa treatment for the movement disorder. In PD, OH can occur early in the disease, occasionally preceding or overshadowing the movement disorder.
AuthorsDavid S Goldstein
JournalClinical autonomic research : official journal of the Clinical Autonomic Research Society (Clin Auton Res) Vol. 16 Issue 1 Pg. 46-54 (Feb 2006) ISSN: 0959-9851 [Print] Germany
PMID16477495 (Publication Type: Journal Article)
Chemical References
  • Antiparkinson Agents
  • Levodopa
Topics
  • Adult
  • Aged
  • Aged, 80 and over
  • Antiparkinson Agents (therapeutic use)
  • Autonomic Nervous System (physiopathology)
  • Diagnosis, Differential
  • Female
  • Humans
  • Hypotension, Orthostatic (complications, diagnosis, physiopathology)
  • Levodopa (therapeutic use)
  • Male
  • Middle Aged
  • Movement Disorders (complications, diagnosis, physiopathology)
  • Multiple System Atrophy (complications, diagnosis, physiopathology)
  • Parkinson Disease (complications, diagnosis, drug therapy, physiopathology)
  • Time Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: